Bilateral acute anterior uveitis and iris atrophy caused by moxifloxacin

被引:1
作者
Hui, Benjamin Tsun Kiu [1 ]
Capewell, Nicholas [1 ]
Ansari, Yousuf [1 ]
Liu, Xiaoxuan [1 ,2 ,3 ]
机构
[1] Univ Hosp Birmingham NHS Fdn Trust, Dept Ophthalmol, Birmingham, W Midlands, England
[2] Univ Birmingham, Acad Unit Ophthalmol, Coll Med & Dent Sci, Birmingham, W Midlands, England
[3] Moorfields Eye Hosp NHS Fdn Trust, London, England
关键词
iris; anterior chamber; TRANSILLUMINATION;
D O I
10.1136/bcr-2019-233528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 56-year-old paramedic was admitted to hospital and treated for severe pneumonia. Shortly after initiating antibiotic treatment (including moxifloxacin), he developed bilaterally painful eyes and was diagnosed with bilateral acute anterior uveitis (AAU). Three years later, he was referred to the ophthalmology clinic with bilateral iris transillumination suggesting iris atrophy and limited pupillary dilation, indicating iris sphincter muscle paralysis. AAU typically presents unilaterally. An onset of bilateral AAU is unusual and warrants investigation for underlying systemic cause. The fluoroquinolone moxifloxacin has been reported in a limited number of cases as a causative agent of bilateral AAU and iris atrophy. This case provides additional supporting evidence that moxifloxacin may cause degradation of collagen and iris muscle in the eye, as well as elsewhere in the body, such as in blood vessels. Additionally, we present novel anterior segment ocular imaging (using optical coherence tomography) demonstrating the ability to detect iris atrophy using non-invasive imaging.
引用
收藏
页数:4
相关论文
共 20 条
[1]  
Asam JS., 2019, ANTERIOR SEGMENT OCT, P285
[2]   Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin [J].
Bettink-Remeijer, M. Wefers ;
Brouwers, K. ;
van Langenhove, L. ;
De Waard, P. W. T. ;
Missotten, T. O. ;
Ciriano, J. P. Martinez ;
Van Aken, E. .
EYE, 2009, 23 (12) :2260-2262
[3]  
Bringas Calvo R, 2004, Arch Soc Esp Oftalmol, V79, P357
[4]  
Broens A, 2015, Rev Med Liege, V70, P606
[5]  
Cano Parra J, 2005, Arch Soc Esp Oftalmol, V80, P137
[6]   Severe pseudouveitis associated with moxifloxacin therapy [J].
Duncombe, A. ;
Gueudry, J. ;
Massy, N. ;
Chapuzet, C. ;
Gueit, I. ;
Muraine, M. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2013, 36 (02) :146-150
[7]   Degree, duration, and causes of visual loss in uveitis [J].
Durrani, OM ;
Tehrani, NN ;
Marr, JE ;
Moradi, P ;
Stavrou, P ;
Murray, PI .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (09) :1159-1162
[8]   Investigation and management of uveitis [J].
Guly, Catherine M. ;
Forrester, John V. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :821-826
[9]  
Hinkle DM, 2017, OPEN OPHTHALMOL J, V11, P107, DOI 10.2174/1874364101711010107
[10]   Bilateral Acute Iris Transillumination Following Systemic Moxifloxacin for Respiratory Illness: Report of Two Cases and Review of the Literature [J].
Morshedi, R. Grant ;
Bettis, Daniel I. ;
Moshirfar, Majid ;
Vitale, Albert T. .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2012, 20 (04) :266-272